Banque Pictet & Cie Sa Kodiak Sciences Inc. Transaction History
Banque Pictet & Cie Sa
- $14.9 Billion
- Q4 2024
Shares
2 transactions
Others Institutions Holding KOD
# of Institutions
110Shares Held
40.9MCall Options Held
13.8KPut Options Held
5.8K-
Baker Bros. Advisors LP New York, NY17.3MShares$91.1 Million1.91% of portfolio
-
Black Rock Inc. New York, NY3.85MShares$20.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.68MShares$8.85 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA1.53MShares$8.06 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.27MShares$6.67 Million0.0% of portfolio
About Kodiak Sciences Inc.
- Ticker KOD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,040,200
- Market Cap $274M
- Description
- Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...